Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Lisata Therapeutics Inc

LSTA
2,38
-0,02 (-0,83%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202522:05GLOBELisata Therapeutics Reports Full Year 2024 Financial Results..
20/2/202514:00GLOBELisata Therapeutics to Report Full Year 2024 Financial..
05/2/202514:30GLOBELisata Therapeutics to Present at the 2025 BIO CEO &..
23/1/202514:00GLOBELisata Therapeutics and WARPNINE Announce Encouraging..
22/1/202514:00GLOBELisata Therapeutics Reports Encouraging Preliminary Cohort A..
15/1/202514:30GLOBELisata Therapeutics to Present at the 2025 Sequire Investor..
10/12/202414:30GLOBELisata Therapeutics Announces Completion of Enrollment in..
03/12/202414:30GLOBELisata Therapeutics and Kuva Labs Announce Global License..
19/11/202414:30GLOBELisata Therapeutics Wins 2024 BioTech Breakthrough Award for..
12/11/202422:05GLOBELisata Therapeutics Reports Third Quarter 2024 Financial..
06/11/202415:23GLOBELisata Therapeutics and Valo Therapeutics Announce..
06/11/202414:30GLOBELisata Therapeutics to Report Third Quarter 2024 Financial..
31/10/202413:30GLOBELisata Therapeutics to Participate in Upcoming November 2024..
28/10/202413:30GLOBELisata Therapeutics Announces Sponsored Preclinical Research..
03/10/202414:00GLOBELisata Therapeutics to Participate in Upcoming October 2024..
17/9/202414:00GLOBELisata Therapeutics Announces First Patient Treated in the..
09/9/202414:00GLOBELisata Therapeutics to Participate in Upcoming September..
05/9/202414:00GLOBELisata Therapeutics’ Certepetide Granted FDA Orphan Drug..
12/8/202422:05GLOBELisata Therapeutics Reports Second Quarter 2024 Financial..
05/8/202414:00GLOBELisata Therapeutics to Report Second Quarter 2024 Financial..
18/7/202414:00GLOBEHaystack Oncology and Lisata Therapeutics Initiate Research..
16/7/202414:00GLOBELisata Therapeutics Announces Completion of Enrollment in..
10/7/202414:00GLOBELisata Therapeutics’ Certepetide Shows Promise in Improving..
13/6/202414:30GLOBELisata Therapeutics Announces Full Enrollment of Pancreatic..
28/5/202414:30GLOBELisata Therapeutics to Participate in Upcoming June 2024..
20/5/202414:30GLOBELisata Therapeutics Receives Paediatric Investigation Plan..
10/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
09/5/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:05GLOBELisata Therapeutics Reports First Quarter 2024 Financial..
08/5/202414:00GLOBELisata Therapeutics to Participate in Upcoming May 2024..
02/5/202414:00GLOBELisata Therapeutics to Report First Quarter 2024 Financial..
23/4/202413:30GLOBELisata Therapeutics and Qilu Pharmaceutical Announce First..
09/4/202414:30GLOBELisata Therapeutics Announces U.S. FDA Orphan Drug..
03/4/202414:30GLOBELisata Therapeutics to Participate in Upcoming April 2024..
21/3/202413:00GLOBELisata Therapeutics Announces U.S. FDA Rare Pediatric..
04/3/202414:00GLOBELisata Therapeutics to Present at the Life Science Investor..
Apertura: 2,31 Min: 2,2592 Max: 2,37
Chiusura: 2,40

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network